FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · FDA: PRESS ANNOUNCEMENTS · 20 October 2026

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment

Synopsis

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment Chronic hepatitis B is a long-term liver infection caused by HBV.

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at FDA: press announcements ↗

More in New medicines and drug discovery